AIQ Solutions develops the TRAQinform IQ software medical device, which quantifies changes in cancer lesions over time using serial radiographic images. This technology enables oncologists to tailor treatment regimens for late-stage cancer patients, addressing the challenge of treatment response heterogeneity that can significantly impact clinical outcomes.

The startup develops a cardiac monitoring device that provides continuous atrial electrograms for the diagnosis of atrial arrhythmias. This technology enables healthcare providers to enhance patient outcomes by facilitating real-time monitoring and treatment of these conditions.

BrainXell specializes in producing high-purity, iPSC-derived human neurons, astrocytes, and microglia for research and drug discovery in central nervous system disorders. The company provides customizable cell lines in various quantities, enabling researchers to advance their studies with precise, patient-derived cellular models.

Cella accelerates the natural geologic process of turning carbon dioxide into stable mineral rock for permanent sequestration. The company injects captured atmospheric CO2 into volcanic formations where mineralization securely locks the carbon underground. This technology offers a scalable, verifiable solution for long-term carbon removal storage.

Cellular Logistics develops a cellular biomaterial designed for therapeutic applications in cardiac repair and tissue vascularization. This technology addresses the challenge of regenerating damaged heart tissue, offering a targeted solution for heart disease treatment.

The startup produces a scientifically-backed allergy supplement formulated with all-natural ingredients to provide rapid relief from itching in pets. This product addresses the common issue of pet discomfort due to allergies, enhancing overall pet wellness.

DataChat is a no-code conversational intelligence platform that enables business users to query their data in plain English, facilitating rapid access to insights without the need for technical expertise. By allowing iterative analytics and maintaining data security within the user's database, DataChat streamlines the decision-making process and enhances data-driven operations.

Design Therapeutics is developing small molecule therapeutic candidates through its GeneTAC™ platform to target the underlying causes of serious genetic disorders, such as Friedreich ataxia and Huntington’s disease. The company addresses the urgent medical need for functional cures in monogenic repeat expansion disorders, which currently lack effective treatment options.

Dianomi Therapeutics is developing targeted therapies for osteoarthritis by utilizing advanced anti-inflammatory compounds to reduce joint pain and improve mobility. The company addresses the significant unmet need for effective treatments in inflammatory diseases, enhancing the quality of life for affected patients.

The startup develops a weather prediction tool that utilizes local weather history and advanced disease prediction models to assess crop disease risk for U.S. corn and soybean growers. This software enables farmers to make informed decisions, ultimately reducing costs and enhancing agricultural sustainability.

Gregor Diagnostics is developing a suite of semen-based genomic classifier tests to enhance prostate cancer screening and monitoring, providing high sensitivity and specificity while minimizing the need for invasive biopsies. The technology addresses the limitations of current diagnostics, which often lead to overdiagnosis and unnecessary treatments in a significant number of patients.

Hubble is a centralized platform for political campaigns that integrates voter, donor, and contact management with tools for fundraising, compliance, and communication. It eliminates delays in accessing voter data and streamlines campaign operations, allowing candidates to focus on engaging their communities.

Provides program management software designed specifically for multi-team hardware development, enabling seamless coordination across complex projects with nested hierarchies that reflect real-world systems. It addresses the challenges of task visibility, stakeholder alignment, and data security by supporting ITAR, GovCloud, and SOC II compliance, while integrating with tools like Excel, Jira, and Smartsheet for streamlined workflows.

Leo Cancer Care provides an upright radiotherapy platform that rotates the patient instead of a massive gantry, integrating a fan‑beam CT scanner for on‑site simulation, imaging, and treatment in a compact room.

One is a financial technology platform that offers mobile banking services, including high-yield savings accounts with a 4.35% APY, early direct deposit, and cash back rewards at select retailers. The platform addresses the need for low-cost banking solutions by eliminating monthly fees and providing tools for credit building without interest or credit checks.

PROMISS Diagnostics develops a non-invasive diagnostic test specifically for ovarian cancer detection. This technology aims to provide clinicians with a precise tool for identifying the disease at early stages when survival rates are highest. The company focuses on improving patient outcomes while addressing the unmet need for accessible and efficacious ovarian cancer screening.

Pyran utilizes a proprietary clean technology to convert renewable agricultural products into 1,5-pentanediol (1,5-PDO), a biobased diol that offers superior performance in heat, water, and weather resistance compared to traditional 6-carbon diols. This innovation addresses the high cost and limited availability of 5-carbon molecules, providing a sustainable alternative for manufacturers of paints, coatings, and plastics.

Science is a clinical-stage technology company developing biohybrid neural interfaces and advanced neural recording electronics to address serious unmet medical needs in neuroscience. Their technologies aim to enhance neural communication and restore vision, facilitating new treatment possibilities for patients with neurological disorders.

The startup develops stem cell-derived in vitro models of the central nervous system using functionalized multi-arm polyethylene glycol monomers cross-linked with bioactive peptides to create hydrogels. These models provide researchers and clinicians with reliable cell-based assays for drug discovery and toxicology testing, addressing the need for more accurate disease modeling.

Stuart Therapeutics develops PolyCol, a therapeutic platform utilizing synthetic amino acid sequences to specifically bind to and repair disease-damaged helical collagen in the extracellular matrix. This technology targets chronic ocular conditions such as Dry Eye Disease, Glaucoma, and Dry Age-Related Macular Degeneration, which lead to inflammation, pain, and vision loss.

Provides a cloud-based platform that uses AI to instantly create and deploy custom apps, games, and interactive experiences for online communities. It eliminates the need for coding or manual setup, enabling community managers and creators to engage members with tailored tools like event organizers, leaderboards, and virtual games in real time.

Voximetry provides personalized dosimetry services for radiopharmaceutical therapy (RPT), utilizing GPU-accelerated technology to analyze nuclear medicine scans and calculate patient-specific doses. This approach addresses the variability in treatment response among cancer patients, ensuring more accurate and effective therapy delivery without the need for in-house software deployment.

WiscMed has developed a medical device that utilizes advanced optical technology to provide high-resolution imaging of the eardrum. This enhanced visualization aids healthcare professionals in accurately diagnosing and treating ear conditions, improving patient outcomes.